<!DOCTYPE html>
<!-- Generated by pkgdown: do not edit by hand --><html lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta charset="utf-8"><meta http-equiv="X-UA-Compatible" content="IE=edge"><meta name="viewport" content="width=device-width, initial-scale=1.0"><title>ARE method for composite binary endpoints — ARE_cbe • CompAREdesign</title><!-- favicons --><link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png"><link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png"><link rel="apple-touch-icon" type="image/png" sizes="180x180" href="../apple-touch-icon.png"><link rel="apple-touch-icon" type="image/png" sizes="120x120" href="../apple-touch-icon-120x120.png"><link rel="apple-touch-icon" type="image/png" sizes="76x76" href="../apple-touch-icon-76x76.png"><link rel="apple-touch-icon" type="image/png" sizes="60x60" href="../apple-touch-icon-60x60.png"><!-- jquery --><script src="https://cdnjs.cloudflare.com/ajax/libs/jquery/3.4.1/jquery.min.js" integrity="sha256-CSXorXvZcTkaix6Yvo6HppcZGetbYMGWSFlBw8HfCJo=" crossorigin="anonymous"></script><!-- Bootstrap --><link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/twitter-bootstrap/3.4.1/css/bootstrap.min.css" integrity="sha256-bZLfwXAP04zRMK2BjiO8iu9pf4FbLqX6zitd+tIvLhE=" crossorigin="anonymous"><script src="https://cdnjs.cloudflare.com/ajax/libs/twitter-bootstrap/3.4.1/js/bootstrap.min.js" integrity="sha256-nuL8/2cJ5NDSSwnKD8VqreErSWHtnEP9E7AySL+1ev4=" crossorigin="anonymous"></script><!-- bootstrap-toc --><link rel="stylesheet" href="../bootstrap-toc.css"><script src="../bootstrap-toc.js"></script><!-- Font Awesome icons --><link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/all.min.css" integrity="sha256-mmgLkCYLUQbXn0B1SRqzHar6dCnv9oZFPEC1g1cwlkk=" crossorigin="anonymous"><link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/v4-shims.min.css" integrity="sha256-wZjR52fzng1pJHwx4aV2AO3yyTOXrcDW7jBpJtTwVxw=" crossorigin="anonymous"><!-- clipboard.js --><script src="https://cdnjs.cloudflare.com/ajax/libs/clipboard.js/2.0.6/clipboard.min.js" integrity="sha256-inc5kl9MA1hkeYUt+EC3BhlIgyp/2jDIyBLS6k3UxPI=" crossorigin="anonymous"></script><!-- headroom.js --><script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/headroom.min.js" integrity="sha256-AsUX4SJE1+yuDu5+mAVzJbuYNPHj/WroHuZ8Ir/CkE0=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/jQuery.headroom.min.js" integrity="sha256-ZX/yNShbjqsohH1k95liqY9Gd8uOiE1S4vZc+9KQ1K4=" crossorigin="anonymous"></script><!-- pkgdown --><link href="../pkgdown.css" rel="stylesheet"><script src="../pkgdown.js"></script><meta property="og:title" content="ARE method for composite binary endpoints — ARE_cbe"><meta property="og:description" content="The composite endpoint is assumed to be a binary endpoint formed by a combination of two events (E1 and E2). We assume that the endpoint 1 is more relevant for the clinical question than endpoint 2. 
This function calculates the ARE method for binary endpoints. The method quantifies the differences in efficiency of using the composite or the relevant as primary endpoint to lead the trial and, moreover, provides a decision rule to choose the primary endpoint. If the ARE is larger than 1, the composite endpoint may be considered the best option as primary endpoint. Otherwise, the relevant endpoint is preferred."><meta property="og:image" content="/logo.png"><!-- mathjax --><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/MathJax.js" integrity="sha256-nvJJv9wWKEm88qvoQl9ekL2J+k/RWIsaSScxxlsrv8k=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/config/TeX-AMS-MML_HTMLorMML.js" integrity="sha256-84DKXVJXs0/F8OTMzX4UR909+jtl4G7SPypPavF+GfA=" crossorigin="anonymous"></script><!--[if lt IE 9]>
<script src="https://oss.maxcdn.com/html5shiv/3.7.3/html5shiv.min.js"></script>
<script src="https://oss.maxcdn.com/respond/1.4.2/respond.min.js"></script>
<![endif]--></head><body data-spy="scroll" data-target="#toc">
    

    <div class="container template-reference-topic">
      <header><div class="navbar navbar-default navbar-fixed-top" role="navigation">
  <div class="container">
    <div class="navbar-header">
      <button type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-target="#navbar" aria-expanded="false">
        <span class="sr-only">Toggle navigation</span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
      </button>
      <span class="navbar-brand">
        <a class="navbar-link" href="../index.html">CompAREdesign</a>
        <span class="version label label-default" data-toggle="tooltip" data-placement="bottom" title="">2.1</span>
      </span>
    </div>

    <div id="navbar" class="navbar-collapse collapse">
      <ul class="nav navbar-nav"><li>
  <a href="../reference/index.html">Reference</a>
</li>
      </ul><ul class="nav navbar-nav navbar-right"></ul></div><!--/.nav-collapse -->
  </div><!--/.container -->
</div><!--/.navbar -->

      

      </header><div class="row">
  <div class="col-md-9 contents">
    <div class="page-header">
    <h1>ARE method for composite binary endpoints</h1>
    
    <div class="hidden name"><code>ARE_cbe.Rd</code></div>
    </div>

    <div class="ref-description">
    <p>The composite endpoint is assumed to be a binary endpoint formed by a combination of two events (E1 and E2). We assume that the endpoint 1 is more relevant for the clinical question than endpoint 2. 
This function calculates the ARE method for binary endpoints. The method quantifies the differences in efficiency of using the composite or the relevant as primary endpoint to lead the trial and, moreover, provides a decision rule to choose the primary endpoint. If the ARE is larger than 1, the composite endpoint may be considered the best option as primary endpoint. Otherwise, the relevant endpoint is preferred.</p>
    </div>

    <div id="ref-usage">
    <div class="sourceCode"><pre class="sourceCode r"><code><span><span class="fu">ARE_cbe</span><span class="op">(</span></span>
<span>  <span class="va">p0_e1</span>,</span>
<span>  <span class="va">p0_e2</span>,</span>
<span>  <span class="va">eff_e1</span>,</span>
<span>  effm_e1 <span class="op">=</span> <span class="st">"or"</span>,</span>
<span>  <span class="va">eff_e2</span>,</span>
<span>  effm_e2 <span class="op">=</span> <span class="st">"or"</span>,</span>
<span>  effm_ce <span class="op">=</span> <span class="st">"or"</span>,</span>
<span>  <span class="va">rho</span></span>
<span><span class="op">)</span></span></code></pre></div>
    </div>

    <div id="arguments">
    <h2>Arguments</h2>
    <dl><dt>p0_e1</dt>
<dd><p>numeric parameter, probability of occurrence E1 in the control group</p></dd>


<dt>p0_e2</dt>
<dd><p>numeric parameter, probability of occurrence E2 in the control group</p></dd>


<dt>eff_e1</dt>
<dd><p>numeric parameter, anticipated effect for the composite component E1</p></dd>


<dt>effm_e1</dt>
<dd><p>Effect measure used for the event E1  (effm_e1 = "diff" for difference of proportions, effm_e1 = "rr" for risk ratio, effm_e1 = "or" for odds ratio)</p></dd>


<dt>eff_e2</dt>
<dd><p>numeric parameter, anticipated effect for the composite component E2</p></dd>


<dt>effm_e2</dt>
<dd><p>Effect measure used for the event E2  (effm_e2 = "diff" for difference of proportions, effm_e2 = "rr" for risk ratio, effm_e2 = "or" for odds ratio)</p></dd>


<dt>effm_ce</dt>
<dd><p>Effect measure used for the composite endpoint (effm_ce = "diff" for difference of proportions, effm_ce = "rr" for risk ratio, effm_ce = "or" for odds ratio)</p></dd>


<dt>rho</dt>
<dd><p>numeric parameter, Pearson's correlation between the two events E1 and E2</p></dd>

</dl></div>
    <div id="value">
    <h2>Value</h2>
    

<p>Returns the ARE value. If the ARE value is larger than 1 then the composite endpoint is preferred over the relevant endpoint. Otherwise, the endpoint 1 is preferred as the primary endpoint of the study.</p>
    </div>
    <div id="details">
    <h2>Details</h2>
    <p>The input parameters stand for the probability of the composite components and Pearson's correlation between the two components.
Note that Pearson's correlation takes values between two bounds that depend on the probabilities p0_e1 and p0_e2.
To calculate the correlation bounds you can use the R functions lower_corr and upper_corr, available in this package.</p>
    </div>
    <div id="references">
    <h2>References</h2>
    <p>Bofill Roig, M., &amp; Gomez Melis, G. (2018). Selection of composite binary endpoints in clinical trials. Biometrical Journal, 60(2), 246-261. https://doi.org/10.1002/bimj.201600229</p>
    </div>

  </div>
  <div class="col-md-3 hidden-xs hidden-sm" id="pkgdown-sidebar">
    <nav id="toc" data-toggle="toc" class="sticky-top"><h2 data-toc-skip>Contents</h2>
    </nav></div>
</div>


      <footer><div class="copyright">
  <p></p><p>Developed by Marta Bofill Roig, Jordi Cortes Martinez.</p>
</div>

<div class="pkgdown">
  <p></p><p>Site built with <a href="https://pkgdown.r-lib.org/" class="external-link">pkgdown</a> 2.0.6.</p>
</div>

      </footer></div>

  


  

  </body></html>

